Please refer the attached file for further details

October 15, 2026 Ref. No: HDFC Life/CA/2026-27/40 Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No C/1, Block G, Sir PJ Towers, Bandra-Kurla Complex, Dalal Street, Bandra (East), Fort, Mumbai – 400 051 Mumbai – 400 001 NSE Symbol: HDFCLIFE BSE Security Code: 540777 Dear Sir/ Madam, Sub: Outcome of the Board Meeting held on October 15, 2026 We wish to inform that the Board of Directors of HDFC Life Insurance Company Limited (“Company”) at their meeting held today i.e. Thursday, October 15, 2026, have inter-alia approved the following: 1. Financial Results The un-audited standalone and consolidated financial results for the quarter and half- year ended September 30, 2026, which have been subject to limited review by M/s BSR & Co. LLP and M/s KKC & Associates LLP, Chartered Accountants, Joint Statutory Auditors of the Company. In terms of Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the above financial results along with the Limited Review Reports for the quarter and half-year ended September 30, 2026 are enclosed herewith. 2. In-principle approval for raising of funds through issuance of Non-Convertible Debentures (NCDs) Fund raising through issuance of NCDs in the nature of subordinated debt instruments up to ₹ 500 crore (Rupees five hundred crore only) in one or more tranches, in accordance with the SEBI (Issue and Listing of Non-Convertible Securities) Regulations, 2021 and IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024 and other applicable regulations and circulars, on private placement basis. 3. Establishment of International Financial Services Centre (“IFSC”) Insurance Office (“IIO”), at Gujarat International Finance Tec-City (“GIFT”), IFSC The establishment of an IIO of the Company at GIFT IFSC will enable the Company to leverage the opportunities available within the IFSC ecosystem. The establishment of the IIO would be subject to approvals from the Insurance Regulatory and Development Authority of India (IRDAI), IFSC Authority, and the shareholders. Pursuant to the IRDAI (Protection of Policyholders’ Interests, Operations and Allied Matters of Insurers) Regulations, 2024, the above matter requires the approval of the shareholders. Accordingly, the Company will be seeking shareholder approval through a postal ballot process, and the notice of postal ballot will be disseminated in due course. The meeting of the Board commenced at 1.15 p.m. and concluded at 3.40 p.m. (IST) This is for your information and appropriate dissemination. For HDFC Life Insurance Company Limited Niraj Shah Executive Director & Chief Financial Officer Encl.: As above B S R & Co. LLP KKC & Associates LLP Chartered Accountants Chartered Accountants (Formerly Khimji Kunverji & Co LLP) 14th Floor, Central B Wing and North C Wing, Level 19, Sunshine Tower, Nesco IT Park 4, Nesco Center, Senapati Bapat Marg, Western Express Highway, Elphinstone Road, Goregaon (East), Mumbai – 400 013 Mumbai, India – 400 063 India Telephone +91 22 6257 1000 Telephone +91 22 6413 7333 Fax +91 22 6257 1010 Limited Review Report on statement of unaudited standalone financial results of HDFC Life Insurance Company Limited for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 pursuant to Regulation 33 and Regulation 52(4) read with Regulation 63 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with the Insurance Regulatory and Development Authority of India’s circular bearing reference no: IRDAI/F&I/REG/CIR/208/10/2016 dated 25 October 2016 To The Board of Directors of HDFC Life Insurance Company Limited 1. We have reviewed the accompanying statement of unaudited standalone financial results of HDFC Life Insurance Company Limited (hereinafter referred to as the “Company”) for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026, being submitted by the Company pursuant to the requirement of Regulation 33 and Regulation 52(4) read with Regulation 63 of the Securities and Exchange Board of India (“SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”) and the Insurance Regulatory and Development Authority of India (“IRDAI”/ the “Authority”) Circular reference no. IRDAI/F&I/REG/CIR/208/10/2016 dated 25 October 2016 (“IRDAI Circular”) (the “Statement”). 2. This Statement, which is the responsibility of the Company’s Management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Accounting Standard 25 “Interim Financial Reporting” (“AS 25”), as prescribed under Section 133 of the Companies Act, 2013 (the “Act”), applicable rules thereto along with the other accounting principles generally accepted in India, read with the accounting and presentation principles as prescribed in the relevant provisions of the Insurance Act, 1938 (the “Insurance Act”) as amended from time to time, the Insurance Regulatory and Development Authority Act, 1999 (the “IRDA Act”) as amended from time to time, and Insurance Regulatory and Development Authority of India (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024, as amended (the “Regulations”) and orders/directions/circulars issued by IRDAI, to the extent applicable, and has been presented in accordance with the presentation and disclosure requirements prescribed as per the IRDAI Circular and the Listing Regulations, to the extent applicable. Our responsibility is to issue a report on these Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India (the “ICAI”). This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Page 1 of 2 B S R & Co. LLP KKC & Associates LLP 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the requirements of the recognition and measurement principles laid down in AS 25, as prescribed under Section 133 of the Act, applicable rules thereto along with the other accounting principles generally accepted in India, read with the accounting and presentation principles as prescribed in the relevant provisions of the Insurance Act, the IRDA Act and the Regulations, orders/directions/circulars issued by the IRDAI to the extent applicable and other recognized accounting practices and policies, has not disclosed the information required to be disclosed in terms of Regulation 33 and Regulation 52(4) read with Regulation 63 of the Listing Regulations and the IRDAI Circular, including the manner in which it is to be disclosed, or that it contains any material misstatement. Other Matters 5. The actuarial valuation of liabilities for life policies in force and for policies in respect of which premium has been discontinued but liability exists as at 30 September 2026 is the responsibility of the Company’s Appointed Actuary (the “Appointed Actuary”). The actuarial valuation of these liabilities for life policies in force and for policies in respect of which premium has been discontinued but liability exists as at 30 [Showing first 8,000 characters — download PDF for full document]